Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LNPEP | Q9UIQ6 | 6/20 | 0.68 |
| ▸ | ANPEP | P15144 | 3/20 | 0.68 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.56 |
| ▸ | AGTR2 | P50052 | 4/20 | 0.55 |
| ▸ | AGTR1 | P30556 | 3/20 | 0.55 |
| ▸ | REN | P00797 | 3/20 | 0.54 |
| ▸ | DPP3 | Q9NY33 | 3/20 | 0.53 |
| ▸ | CMA1 | P23946 | 3/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29638291 | 0.97 | LNPEP (0.66) | LNPEPANPEPSLC6A2AGTR2AGTR1 | |
| SCHEMBL29638293 | 0.93 | LNPEP (0.63) | LNPEPANPEPSLC6A2REN | |
| SCHEMBL31121210 | 0.92 | LNPEP (0.66) | LNPEPANPEPSLC6A2AGTR2AGTR1 | |
| SCHEMBL29638285 | 0.90 | LNPEP (0.62) | LNPEPANPEPREN | |
| SCHEMBL29638299 | 0.89 | LNPEP (0.63) | LNPEPANPEPSLC6A2AGTR2AGTR1 | |
| SCHEMBL29392664 | 0.89 | LNPEP (0.65) | LNPEPANPEPSLC6A2RENDPP3 | |
| SCHEMBL30434308 | 0.89 | LNPEP (0.59) | LNPEPANPEPSLC6A2AGTR2AGTR1 | |
| SCHEMBL29638290 | 0.88 | LNPEP (0.56) | LNPEPANPEPSLC6A2RENDPP3 | |
| SCHEMBL29638298 | 0.88 | LNPEP (0.62) | LNPEPANPEPSLC6A2RENDPP3 | |
| SCHEMBL30695688 | 0.88 | SLC6A2 (0.55) | LNPEPANPEPSLC6A2RENDPP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109400683-B | Antitumor cyclic peptide and preparation method and application thereof | 安徽工程大学 | 2022-05-17 | — | — | CN | disclosed |